Hanmi Pharm. Co., Ltd. (KOSE: A128940)
Health Care · Pharmaceuticals · KR
₩415,500.00
+4.27% today · +43.3% 1Y
Hanmi Pharm. Co., Ltd. (KOSE: A128940) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.80B.
Over the last twelve months the share price has gained 43.3%, trading between 281.00K and 647.00K.
Tweenvest scores Hanmi Pharm. Co., Ltd. across four factors: quality 67/100, value 39/100, dividend 4/100. Its strongest factor is quality.
A128940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.80B
- Revenue (TTM)
- $1.07B
- P/E
- 24.30
- EPS
- 17,099.54
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.49
- 52-week high
- ₩647,000.00
- 52-week low
- ₩281,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.69M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,248.49 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.78 | -0.10% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.08 | +2.93% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.39 | +1.48% |
Figures last refreshed Aug 18, 2026.